953 related articles for article (PubMed ID: 19840564)
1. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
2. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
3. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and effects on long-term outcomes of cardiac troponin I elevation after drug-eluting stent implantation in patients with stable coronary artery disease.
Koh JS; Park JH; Shin DH; Youn TJ; Oh IY; Yoon CH; Suh JW; Cho YS; Cho GY; Chae IH; Choi DJ
Am J Cardiol; 2012 Feb; 109(4):461-5. PubMed ID: 22133750
[TBL] [Abstract][Full Text] [Related]
5. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
[TBL] [Abstract][Full Text] [Related]
6. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
10. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.
Prasad A; Singh M; Lerman A; Lennon RJ; Holmes DR; Rihal CS
J Am Coll Cardiol; 2006 Nov; 48(9):1765-70. PubMed ID: 17084247
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
[TBL] [Abstract][Full Text] [Related]
12. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
[TBL] [Abstract][Full Text] [Related]
13. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
Chen WH; Lee PY; Ng W; Tse HF; Lau CP
J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
[TBL] [Abstract][Full Text] [Related]
14. Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.
Karha J; Gurm HS; Rajagopal V; Fathi R; Bavry AA; Brener SJ; Lincoff AM; Ellis SG; Bhatt DL
Am J Cardiol; 2006 Oct; 98(7):906-10. PubMed ID: 16996871
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
[TBL] [Abstract][Full Text] [Related]
17. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.
Prasad A; Rihal CS; Lennon RJ; Singh M; Jaffe AS; Holmes DR
Circ Cardiovasc Interv; 2008 Aug; 1(1):10-9. PubMed ID: 20031650
[TBL] [Abstract][Full Text] [Related]
18. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
20. Predictors and prognostic value of myocardial injury following stent implantation.
Ramírez-Moreno A; Cardenal R; Pera C; Pagola C; Guzmán M; Vázquez E; Fajardo A; Lozano C; Solís J; Gassó M
Int J Cardiol; 2004 Nov; 97(2):193-8. PubMed ID: 15458683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]